International Markets

Aiming to improve the quality of life with its effective and high quality products manufactured according to international standards, Nobel carries out promotional and sales activities with its own organizations in Germany, Albania, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Georgia, Switzerland, Montenegro, Kazakhstan, Kyrgyzstan, Kosovo, Lithuania, North Macedonia, Mongolia, Moldova, Uzbekistan, Romania, Russia, Serbia, Tajikistan, Turkmenistan, Ukraine.

International Markets

International Markets

Dedicated to elevating quality of life through efficacious, high-quality pharmaceutical products manufactured in strict compliance with international standards, Nobel operates through its own proprietary organizations in a total of 24 countries, including Germany, Albania, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Georgia, Switzerland, Montenegro, Kazakhstan, Kyrgyzstan, Kosovo, Lithuania, North Macedonia, Mongolia, Moldova, Uzbekistan, Romania, Russia, Serbia, Tajikistan, Turkmenistan, and Ukraine.

A Robust International Footprint in Pharmaceuticals

By deploying dedicated local organizations in every operational market, Nobel Pharmaceuticals executes its field and operational activities in absolute alignment with the long-standing ethical principles and professional standards that define its core operations in Türkiye. This approach ensures seamless consistency across all phases of pharmaceutical development, production, and delivery.

The inaugural milestone of Nobel Pharmaceuticals’ global expansion strategy, as a subsidiary of Ulkar Holding, was achieved in Kazakhstan. Established in 2002 as Nobel AFF, this manufacturing facility became the country’s first foreign-invested pharmaceutical production plant. It further secured a landmark regulatory achievement as the first facility in Kazakhstan to be awarded GMP certification, validating its compliance with international quality standards in pharmaceutical manufacturing.

Today, the Kazakhstan facility operates with a workforce of approximately 500 employees. Beyond its manufacturing excellence, the site serves as a comprehensive R&D hub with capabilities covering the entire pharmaceutical development lifecycle. These competencies encompass the development of generic formulations and drug delivery systems, solid and liquid dosage form design (including modified- and delayed-release tablets, capsules, and oral liquids), as well as analytical method development, validation, and specification setting. The center also conducts bioequivalence and biopharmaceutical studies, stability testing, and the preparation of regulatory dossiers, delivering end-to-end support from initial formulation to final registration.

Another pivotal achievement within Central Asia is Nobel Pharmsanoat in Uzbekistan. Employing a workforce of over 300 professionals, Nobel Pharmsanoat has established itself as a highly respected Turkish pharmaceutical entity in one of the region’s most demographically significant markets, widely recognized for its unwavering commitment to quality and reliability.

In addition to its production capabilities, the Uzbekistan site functions as an advanced R&D center possessing deep technical expertise in both synthetic and plant-derived active substances. Its scope of operations includes the development of generic formulations and drug delivery systems, analytical method development for raw materials and finished products, and a broad spectrum of solid and liquid dosage form technologies. The center also drives powder formulation development, method validation, stability studies, bioequivalence research, technology transfer processes, and the compilation of regulatory documentation, driving a fully integrated pharmaceutical development capability across the region.

Strengthening Global Reach Through Strategic Partnerships

Complementing its sales and marketing organizations across 24 countries, Nobel continues to strengthen its global presence through long-term collaborations with strong local and international business partners. Through these strategic partnerships, Nobel aims to make its high-quality, life-saving pharmaceutical products accessible to patients worldwide.

With a fast, flexible, and solution-oriented approach, Nobel utilizes a variety of business models to effectively address client expectations and meet country-specific requirements.

  • Distribution Partnerships
  • Licensing & Supply Partnerships
  • Contract Manufacturing Partnerships
  • Co-development / Co-operation Partnerships
  • Active Pharmaceutical Ingredient (API) Sales

For any of the above cooperation oportunities for the international markets, please contact us via;

E-mail: internationalmarkets@nobel.com.tr
T: +90 216 633 60 00
F: +90 216 633 60 01